О генетике эмфиземы легких
https://doi.org/10.18093/0869-0189-2011-0-4-97-108
Аннотация
О генетике эмфиземы легких.
Об авторе
Т. В. Ивчик
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Россия
Россия
д. м. н., ведущий научный сотрудник отдела молекулярно-генетических технологий НИЦ
197089, Санкт-Петербург, ул. Льва Толстого, 6 / 8
Список литературы
1. Пузырев В.П. Генетика мультифакториальных заболеваний между прошлым и будущим. Мед. генетика 2003; 12: 498–508.
2. Silverman E.K., Mosley J.D., Palmer L.J. et al. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum. Mol. Genet. 2002; 11: 623–632.
3. Silverman E.K., Palmer L.J., Mosley J.D. et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am. J. Hum. Genet. 2002; 70: 1229–1239.
4. Palmer L.J., Celedon J.C., Chapman H.A. et al. Genomewide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum. Mol. Genet. 2003; 12: 1199–1210.
5. DeMeo D.L., Celedon J.C., Lange C. et al. Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 170: 1294–1301.
6. Silverman E.K., Chapman H.A., Drazen J.M. et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med. 1998; 157: 1770–1778.
7. Malhotra A., Peiffer A.P., Ryujin.DT. et al. Further evidence for the role of genes on chromosome 2 and chromosome 5 in the inheritance of pulmonary function. Am. J. Respir. Crit. Care Med. 2003; 168: 556–561.
8. DeMeo D.L., Mariani T.J., Lange C. et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am. J. Hum. Genet. 2006; 78: 253–264.
9. Spira A., Beane J., Pinto)Plata V. et al. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am. J. Respir. Cell. Mol. Biol. 2004; 31: 601–610.
10. Hersh C.P., DeMeo D.L., Silverman E.K. Chronic obstructive pulmonary disease. In: Silverman E.K., Shapiro S.D., Lomas D.A., Weiss S.T. (eds.). Respiratory genetics. New York: Hodder Arnold; 2005. 253–296.
11. Shapiro S.D. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur. Respir. J. 2007; 29: 375–378.
12. Zhu G., Warren L., Aponte J. et al. The International COPD Genetics Network (ICGN) Investigators, Anderson W.H., Lomas D.A., Silverman E.K., Pillai S.G. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am. J. Respir. Crit. Care Med. 2007; 176: 167–173.
13. Palmer L.J., Celedon J.C., Chapman H.A. et al. Genomewide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum. Mol. Genet. 2003; 12: 1199–1210.
14. Celedon J.C., Lange C., Raby B.A. et al. The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). Hum. Mol. Genet. 2004; 13: 1649–1656.
15. Silverman E.K., Mosley J.D., Palmer L.J. et al. Genomewide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum. Mol. Genet. 2002; 11: 623–632.
16. Poller W., Faber J.P., Scholz S. et al. Mis-sense mutation of alpha1-antichymotrypsin gene associated with chronic lung disease. Lancet 1992; 339: 1538.
17. Poller W., Faber J.P., Weidinger S. et al. A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993; 17: 740–743.
18. Ishii T., Matsuse T., Teramoto S. et al. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 2000; 30: 543–548.
19. Sandford A.J., Chagani T., Weir T.D., Pare P.D. Alpha1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease. Dis. Markers 1998; 13: 257–260.
20. Benetazzo M.G., Gile L.S., Bombieri C. et al. Alpha1-antitrypsin TAQ I polymorphism and alpha1-antichymotrypsin mutations in patients with obstructive pulmonary disease. Respir. Med. 1999; 93: 648–654.
21. Ho L.)I., Harn H.)J., Chen C.)J., Tsai N.)M. Polymorphism of the β2-adrenoceptor in COPD in Chinese subjects. Chest 2001; 120: 1493–1499.
22. Hegab A.E., Sakamoto T., Saitoh W. et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 2004; 126: 1832–1839.
23. Joos L., Weir T.D., Connett J.E. et al. Polymorphisms in the beta2-adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax 2003; 58: 703–707.
24. Brogger J., Steen V.M., Eiken H.G. et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur. Respir. J. 2006; 27: 682–688.
25. Matsushita I., Hasegawa K., Nakata K. et al. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem. Biophys. Res. Commun. 2002; 291: 17–22.
26. Hu R.C., Xu Y.J., Zhang Z.X. et al. Correlation of HDEFB1 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population. Chin. Med. J. (Engl.) 2004; 117: 1637–1641.
27. Wallace A.M., He J.Q., Burkett K.M. et al. Contribution of alpha- and beta-defensins to lung function decline and infection in smokers: an association study. Respir. Res. 2006; 7: 76.
28. Hersh C.P., DeMeo D.L., Raby B.A. et al. Genetic linkage and association analysis of COPD-related traits on chromosome 8p. COPD 2006; 3: 189–194.
29. Smith C.A., Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630–633.
30. Sandford A.J., Chagani T., Weir T.D. et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Respir. Crit. Care Med. 2001; 163: 469–473.
31. Xiao D., Wang C., Du M.J. et al. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease. Chin. Med. J. (Engl.) 2004; 117: 661–667.
32. Demeo D.L., Hersh C.P., Hoffman E.A. et al. Genetic determinants of emphysema distribution in the National Emphysema Treatment Trial. Am. J. Respir. Crit. Care Med. 2007; 176: 42–48.
33. Yoshikawa M., Hiyama K., Ishioka S. et al. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int. J. Mol. Med. 2000; 5: 49–53.
34. Takeyabu K., Yamaguchi E., Suzuki I. et al. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur. Respir. J. 2000; 15: 891–894.
35. Yim J.J., Park G.Y., Lee C.T. et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121–125.
36. Horne S.L., Cockcroft D.W., Dosman J.A. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum. Hered. 1990; 40: 173–176.
37. Schellenberg D., Pare P.D., Weir T.D. et al. Vitamin D binding protein variants and the risk of COPD. Am. J. Respir. Crit. Care Med. 1998; 157: 957–961.
38. Ishii T., Keicho N., Teramoto S. et al. Association of Gcglobulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur. Respir. J. 2001; 18: 753–757.
39. Ito I., Nagai S., Hoshino Y. et al. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest 2004; 125: 63–70.
40. Kauffmann F., Kleisbauer J.P., Cambon)De)Mouzon A. et al. Genetic markers in chronic air-flow limitation: a genetic epidemiologic study. Am. Rev. Respir. Dis. 1983; 127: 263–269.
41. Kasuga I., Pare P.D., Ruan J. et al. Lack of association of group specific component haplotypes with lung function in smokers. Thorax 2003; 58: 790–793.
42. Sandford A.J., Chagani T., Weir T.D. et al. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Respir. Crit. Care Med. 2001; 163: 469–473.
43. Harrison D.J., Cantlay A.M., Rae F. et al. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum. Exp. Toxicol. 1997; 16: 356–360.
44. Baranova H., Perriot J., Albuisson E. et al. Peculiarities of the GSTM1 0 / 0 genotype in French heavy smokers with various types of chronic bronchitis. Hum. Genet. 1997; 99: 822–826.
45. Cheng S.L., Yu C.J., Chen C.J., Yang P.C. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur. Respir. J. 2004; 23: 818–824.
46. Yim J.J., Park G.Y., Lee C.T. et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121–125.
47. He J.)Q., Ruan J., Connett J.E. et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am. J. Respir. Crit. Care Med. 2002; 166: 323–328.
48. Ishii T., Matsuse T., Teramoto S. et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 693–696.
49. Yim J.J., Yoo C.G., Lee C.T. et al. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans. Lung 2002; 180: 119–125.
50. Yamada N., Yamaya M., Okinaga S. et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 2000; 66: 187–195.
51. Guenegou A., Leynaert B., Benessiano J. et al. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample: results from the European Community Respiratory Health Survey (ECRHS), France. J. Med. Genet. 2006; 43: e43.
52. Nakayama K., Kikuchi A., Yasuda H. et al. Heme oxygenase-1 gene promoter polymorphism and decline in lung function in Japanese men. Thorax 2006; 61: 921.
53. Minematsu N., Nakamura H., Tateno H. et al. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem. Biophys. Res. Commun. 2001; 289: 116–119.
54. Zhou M., Huang S.G., Wan H.Y. et al. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China. Chin. Med. J. (Engl.) 2004; 117: 1481–1484.
55. Joos L., He J.Q., Shepherdson M.B. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet. 2002; 11: 569–576.
56. Chappell S., Daly L., Morgan K. et al. The SERPINE2 gene and chronic obstructive pulmonary disease. Am. J. Hum. Genet. 2006; 79: 184–186 (author reply: 186–187).
57. Juul K., Tybjaerg)Hansen A., Marklund S. et al. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 173: 858–864.
58. Young R.P., Hopkins R., Black P.N. et al. Functional variants of antioxidant genes in smokers with COPD and in those with normal lung function. Thorax 2006; 61: 394–399.
59. Guo X., Lin H.M., Lin Z. et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur. Respir. J. 2001; 18: 482–490.
60. Seifart C., Plagens A., Brodje D. et al. Surfactant protein B intron 4 variation in German patients with COPD and acute respiratory failure. Dis. Markers 2002; 18: 129–136.
61. Wu L., Chau J., Young R.P. et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126–129.
62. Su Z.G., Wen F.Q., Feng Y.L. et al. Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol. Sin. 2005; 26: 714–720.
63. van Diemen C.C., Postma D.S., Vonk J.M. et al. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir. Res. 2006; 7: 89.
64. Yoon H.I., Silverman E.K., Lee H.W. et al. Lack of association between COPD and transforming growth factor-beta1 (TGFB1) genetic polymorphisms in Koreans. Int. J. Tuberc. Lung Dis. 2006; 10: 504–509.
65. Ogawa E., Ruan J., Connett J.E. et al. Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers. Respir. Med. 2007; 101: 938–943.
66. Huang S.)L., Su C.)H., Chang S.)C. Tumor necrosis factorgene polymorphism in chronic bronchitis. Am. J. Respir. Crit. Care Med. 1997; 156: 1436–1439.
67. Sakao S., Tatsumi K., Igari H. et al. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 420–422.
68. Matheson M.C., Ellis J.A., Raven J. et al. Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J. Hum. Genet. 2006; 51: 196–203.
69. Higham M.A., Pride N.B., Alikhan A., Morrell N.W. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur. Respir. J. 2000; 15: 281–284.
70. Ishii T., Matsuse T., Teramoto S. et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir. Med. 2000; 94: 847–851.
71. Patuzzo C., Gile L.S., Zorzetto M. et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353–1358.
72. Ferrarotti I., Zorzetto M., Beccaria M. et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur. Respir. J. 2003; 21: 444–449.
73. Chierakul N., Wongwisutikul P., Vejbaesya S., Chotvilaiwan K. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 2005; 10: 36–39.
74. Hegab A.E., Sakamoto T., Saitoh W. et al. Polymorphisms of TNF-alpha, IL1-beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem. Biophys. Res. Commun. 2005; 329: 1246–1252.
75. Jiang L., He B., Zhao M.W. et al. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin. Med. J. (Engl.) 2005; 118: 541–547.
76. Seifart C., Plagens A., Dempfle A. et al. TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis. Markers 2005; 21: 157–165.
77. Ruse C.E., Hill M.C., Tobin M. et al. Tumour necrosis factor gene complex polymorphisms in chronic obstructive pulmonary disease. Respir. Med. 2007; 101: 340–344.
78. Hersh C.P., DeMeo D.L., Silverman E.K. Genetics of Emphysema. Proc. Am. Thorac. Soc. 2008; 5: 486–493.
79. Wilk J.B., Walter R.E., Laramie J.M. et al. Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med. Genet. 2007; 8: S8.
80. Hersh C.P., DeMeo D.L., Lange C. et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am. J. Respir. Cell Mol. Biol. 2005; 33: 71–78.
81. Bell B., Rose C.L., Damon H. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging. Hum. Dev. 1972; 3: 5–17.
82. Hirschhorn J.N., Altshuler D. Once and again-issues surrounding replication in genetic association studies. J. Clin. Endocrinol. Metab. 2002; 87: 4438–4441.
83. Ioannidis J.P., Ntzani E.E., Trikalinos T.A. ContopoulosIoannidis DG. Replication validity of genetic association studies. Nat. Genet. 2001; 29: 306–309.
84. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865–872.
85. Hersh C.P., DeMeo D.L., Lazarus R. et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006; 173: 977–984.
86. Celli B.R., Cote C.G., Marin J.M. et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005–1012.
87. Ito I., Nagai S., Handa T. et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am. J. Respir. Crit. Care Med. 2005; 172: 1378–1382.
88. Fishman A., Martinez F., Naunheim K. et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N. Engl. J. Med. 2003; 348: 2059–2073.
89. Kelleher C.M., Silverman E.K., Broekelmann T. et al. A functional mutation in the terminal exon of elastin in severe, early-onset chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2005; 33: 355–362.
90. Вавилин В.А., Макарова С.И., Ляхович В.В., Гавалов С.М. Ассоциация полиморфных генов ферментов биотрансформации ксенобиотиков с предрасположенностью к бронхиальной астме у детей с наследственной отягощенностью и без таковой. Генетика 2002; 38 (4): 539–545.
91. Сиделева О.Г. Полиморфные аллели генов, ассоциированные с патогенезом атопической формы бронхиальной астмы у жителей северо-запада России: Автореф. дис. … канд. биол. наук. СПб.; 2002.
92. Баранов В.С., Баранова Е.В., Иващенко Т.Э., Асеев М.В. Геном человека и гены "предрасположенности" (Введение в предиктивную медицину). СПб.: Интермедицина; 2000.
93. Пузырев В.П., Севостьянова Н.В., Фрейдин М.Б., Огородникова Л.М. Особенности репаративного синтеза ДНК и полиморфизма генов ферментов биотрансформации ксенобиотиков у больных раком легкого. Пульмонология 2005; 1: 11–15.
94. Пузырев В.П., Сеитова Г.Н., Букреева Е.Б. и др. Роль полиморфизма в промоторной области гена TNF в развитии хронической обструктивной болезни легких. Бюл. Сиб. Мед. 2004; 3 (2): 29–33.
95. Янбаева Д.Г. Ассоциаиции полиморфных вариантов генов ферментов биотрансформации ксенобиотиков, протеолиза-антипротеолиза и цитокинов с хронической обструктивной болезнью легких: Автореф. дис. … канд. биол. наук. Уфа; 2004.
96. Ахмадишина Л.З. Полиморфизм генов ферментов монооксигеназной системы и антиоксидантной защиты у больных хроническими заболеваниями дыхательной системы в республике Башкортостан. Уфа; 2004.
97. Байнак О.В. Клинико-генетические особенности формирования хронической обструктивной болезни легких в республике Башкортостан. Автореф. дис. … канд. мед. наук. Уфа; 2006.
98. Степанищева Л.С., Игнатова Г.Л. Анализ причин, влияющих на возникновение и развитие ХОБЛ у работников машиностроительных предприятий (предварительные результаты). Пульмонология 2005; 4: 11–15.
Рецензия
Для цитирования:
Ивчик Т.В. О генетике эмфиземы легких. Пульмонология. 2011;(4):97-108. https://doi.org/10.18093/0869-0189-2011-0-4-97-108
For citation:
Ivchik T.V. About the genetics of pulmonary emphysema. PULMONOLOGIYA. 2011;(4):97-108. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-4-97-108
Просмотров:
860
Послать статью по эл. почте 